Personalized risk assessment of drug-related harm is associated with health outcomes.
Jones AA, Vila-Rodriguez F, Panenka WJ, Leonova O, Strehlau V, Lang DJ, Thornton AE, Wong H, Barr AM, Procyshyn RM, Smith GN, Buchanan T, Krajden M, Krausz M, Montaner JS, Macewan GW, Nutt DJ, Honer WG.
Jones AA, et al. Among authors: wong h.
PLoS One. 2013 Nov 6;8(11):e79754. doi: 10.1371/journal.pone.0079754. eCollection 2013.
PLoS One. 2013.
PMID: 24223192
Free PMC article.